Celgene Sues Natco To Block Generic Revlimid
Celgene Corp. has slapped India's Natco Pharma Ltd. with a patent infringement lawsuit in an effort to keep a generic version of its top-selling drug Revlimid off the market....To view the full article, register now.
Already a subscriber? Click here to view full article